ATS Stat

Home ▶ ATS Stat ▶ Stat May 19, 2021
Stat May 19, 2021

Welcome ATS President, Lynn Schnapp, MD, ATSF!

At the 2021 ATS International Conference, Lynn Schnapp, MD, ATSF took over as the ATS president for the 2021 - 2022 term. Juan C. Celedón, MD, ATSF became immediate past-president, and the Executive Committee welcomed Irina Petrache, MD, ATSF as the new secretary-treasurer. Gregory Downey, MD, ATSF and M. Patricia Rivera, MD, ATSF became president-elect and vice president, respectively.

Dr. Schnapp was originally elected in 2018. She is the George R. and Elaine Love professor and chair of the Department of Medicine at the University of Wisconsin School of Medicine and Public Health. She is a faculty member in the division of Allergy, Pulmonary and Critical Care Medicine. 

Read more.

 

NIH Announces Updates to NIH-Wide COVID-19 Strategic Plan

NIH has released an updated framework for accelerating the development of therapeutic interventions, vaccines, and diagnostics for SARS-CoV-2 that includes research to investigate and treat the long-term health consequences of COVID-19, as well as to understand and respond to new SARS-CoV-2 variants, and understand and engage disproportionately impacted populations.  The new version of the NIH-Wide Strategic Plan for COVID-19 Research includes key updates to five cross-cutting strategies that are responsive to the evolving needs of the COVID-19 pandemic.

The plan also highlights progress made in the development of diagnostics, therapeutics, and vaccines and developing strategies on how to effectively provide these resources.

Read more about NIH’s strategic response to COVID-19 on the NIH website.

 

Upcoming Events

TB Elimination - Why Not Now? Session 1

Join The Union and the ATS for a webinar series examining if TB Elimination by 2030, the goal set at the UN High Level meeting on TB in September 2018, is still a relevant goal in light of the setbacks as a result of COVID-19.

When: 9 a.m. ET, May 26, 2021
Register now!

 

 “ATS AII Webinar on NAVIGATOR Phase III Trial”

Please join us for a journal club sponsored by the Assembly on Allergy, Immunology featuring the findings from the NAVIGATOR Phase III trial studying tezepelumab anti-TSLP therapy in patients with severe asthma.

When: 4 p.m. ET, June 10, 2021
Register now!

 

Upcoming Twitter Chat!

Join us to discuss, “Nucleic Acid-Based Testing for Non-Influenza Viral Pathogens In Adults With Suspected Community Acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society.”

When: 12 p.m. ET, June 3, 2021
Where: Twitter, using #ATSchat

 

Applications Now Accepted! ATS Fellow Program

Individuals who have been an ATS member for five or more of the past 10 years are eligible to apply to become an ATS Fellow. Applications are submitted via an online application. You may view your application, make edits, or upload a new document at any time until the deadline for submittal.

The ATS Fellow designation is a mark of distinction, conferring recognition on members for their accomplishments, dedication and contributions to the Society as well as to the fields of pulmonary, critical care, and sleep medicine.

Learn more and apply now!

The new ATS Fellows will be announced this fall and recognized at ATS 2022.

Deadline: July 31, 2021 

 

2021 ATS Assembly Mentoring Programs Deadline Approaching!

The ATS Mentoring Programs pair early to mid-career professionals with senior members of their respective assemblies. This virtual program is designed to foster mentoring connections and help mentees grow through individualized attention.

Currently, all ATS Assemblies are offering mentoring programs: 

Please visit our ATS Mentoring Program page to learn more or contact Nicole Feijoo.


Deadline Extended: May 24, 2021